GLP-1 Appeals Letter Template: How To Write A Strong Insurance Appeal For Semaglutide Or Tirzepatide

You finally get a prescription for semaglutide or tirzepatide, you're ready to do this the right way, and then your insurance says no. The denial letter is usually vague, the pharmacy tells you "it needs a prior auth," and you're left wondering whether you missed a form or you're simply out of luck.

A strong GLP-1 appeal is rarely about arguing that the medication is "good." It's about proving medical necessity using your plan's own rules: diagnosis, risk factors, prior treatments, safety, and the exact criteria they require for coverage.

Below you'll find a practical, copy-and-customize GLP-1 appeals letter template (plus the prep work that makes it persuasive). Use it whether you're appealing for semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro or Zepbound).

When You Need A GLP-1 Appeal (And What The Denial Usually Means)

GLP-1 medications can be expensive (often quoted around $12,000 per year without coverage), so insurers commonly deny initial claims even when your clinician prescribes them appropriately. An appeal is your formal request for the plan to reconsider based on clinical facts and the plan's written coverage criteria.

In plain English: a denial doesn't always mean "you don't qualify." It often means "we didn't receive what we require to approve it" or "you need to show you meet our rules."

You typically consider an appeal when:

You were denied after a prior authorization submission

You're told you must try other medications first (step therapy)

Your plan says weight loss medications are excluded

You're approved at one dose but denied at a higher dose due to quantity limits

You were stable on therapy but continuation coverage was stopped

One important detail: denial letters usually include deadlines for appeal (commonly 30 to 180 days, depending on the plan and state rules). Don't wait until you "have time." Build your packet while the denial is fresh and your clinician's documentation is easy to pull.

Common Denial Reasons: Prior Authorization, Step Therapy, Exclusions, Quantity Limits

Prior authorization (PA) not on file or incomplete

This can mean the PA was never submitted, a form field was missing, supporting records weren't attached, or the plan wants specific chart notes (for example, a documented BMI in the past 12 months).

Step therapy ("fail first" requirements)

Your plan may require you to try lower-cost options first (for example, metformin for type 2 diabetes, or other anti-obesity medications for weight management) before covering a GLP-1.

A key appeal strategy here is documenting why the step-therapy option is not appropriate for you: prior failure, contraindication, or intolerance (side effects that made it unsafe or unrealistic).

Exclusions

Some plans exclude weight management drugs entirely, or restrict them to narrow indications. This is one of the toughest scenarios, but it's still worth reading the fine print. Sometimes the exclusion is specific (for example, excluding one brand but not another, or excluding "weight loss" while still covering GLP-1s for type 2 diabetes).

Quantity limits

Your plan may cap the dose, frequency, or number of pens per month. This often shows up during titration (dose escalation) or continuation of therapy. A good appeal clarifies the FDA-labeled dosing schedule and why the requested quantity matches standard of care, not "extra medication."

How To Prepare Before You Write: Documents, Codes, And Clinical Proof

The best appeals are won before the letter is even written. Your goal is to assemble a clean, easy-to-review packet that mirrors how insurance reviewers think: eligibility, criteria, proof.

Think of it like this: you're not writing a persuasive essay. You're building a "checklist match" against the plan's policy.

What To Collect From Your Plan And Pharmacy

Start with the denial letter and treat it like a map.

Collect:

The denial letter (or Explanation of Benefits) showing denial date, denial reason, and appeal deadline

The plan's drug coverage policy or medical policy for the specific GLP-1 (sometimes called coverage criteria, PA criteria, or clinical policy bulletin)

The prior authorization form your clinician submitted (if available)

Your pharmacy's rejection details (they can often tell you the rejection code and whether it's PA, step therapy, or quantity)

Appeal submission instructions, including where to send it (mailing address and/or fax number), and whether an appeal form is required

If your plan offers a member portal, download the criteria as a PDF and highlight the exact requirements you meet. If you can't find the policy, call the number on your insurance card and ask:

Can you send me the clinical criteria for coverage of semaglutide/tirzepatide for my diagnosis?

What is the deadline for an internal appeal?

Where do I submit it (fax number, address, online portal)?

What To Collect From Your Clinician: Diagnosis, BMI, A1C, Comorbidities, Prior Treatments

Your clinician's documentation is the backbone of medical necessity.

Ask for:

Your problem list and diagnoses (for example: type 2 diabetes, prediabetes, obesity, metabolic syndrome)

Your BMI (and weight trend over time, if relevant)

A1C and/or fasting glucose (if diabetes or prediabetes is part of the indication)

Comorbidities that increase cardiometabolic risk (examples: hypertension, dyslipidemia, sleep apnea, NAFLD/MASLD, PCOS, history of gestational diabetes)

A medication history showing prior therapies tried, failed, or not tolerated

A Letter of Medical Necessity (LMN) from your clinician that specifically addresses the denial reason and matches plan criteria

A note about "codes": you don't need to be a billing expert, but it helps to ensure your diagnosis is clearly documented. Insurers often make decisions based on whether the diagnosis and indication align with their policy (and sometimes, whether the request aligns with the FDA-labeled use for that specific brand).

If you're appealing for continuation, also collect:

Start date on therapy

Dose history and adherence

Objective response (weight change, A1C improvement, blood pressure/lipid improvements)

What happened when doses were missed or delayed (if applicable)

Why interruption is medically risky (for example, glycemic worsening, loss of weight-loss response, worsening appetite dysregulation)

How To Structure A Persuasive GLP-1 Appeal Letter

A persuasive GLP-1 appeal letter is short enough to be read quickly, but specific enough to satisfy the reviewer. Most reviewers are scanning for "criteria match," not beautifully written paragraphs.

A practical target is 1 to 2 pages, plus attachments.

Essential Elements: Medical Necessity, Safety, Prior Therapy Failure, And Plan Criteria Matching

Use this structure (and keep the order):

1. Your identifying information

Include your full name, date of birth, member ID, group number (if available), phone number, and address.

2. The denial you're appealing

State the medication, date of denial, and the reason for denial in the plan's own words (quote it).

3. Your clinical snapshot (the "why you" section)

In 3 to 6 bullet points, list the facts that matter:

Diagnosis

BMI

A1C (if relevant)

Key comorbidities

Prior treatments tried and outcomes

Why the requested GLP-1 is medically appropriate

4. Directly match plan criteria

This is the most overlooked step. If the plan criteria says "BMI ≥ 30 or BMI ≥ 27 with a comorbidity," you should explicitly write a sentence that mirrors it.

Example style (you'll customize):

My BMI is 34.2, meeting the plan's BMI requirement for coverage.

I have BMI 29.1 plus hypertension and dyslipidemia, meeting the plan's requirement of BMI ≥ 27 with at least one weight-related comorbidity.

5. Address the denial reason head-on

If it's step therapy, list the agents tried and the problem (ineffective, not tolerated, contraindicated).

If it's prior authorization, clarify what was missing and attach it.

If it's quantity limits, show that the requested quantity matches standard dosing and why it's necessary.

6. Close with a clear request

Ask for reconsideration and approval, and list what you're attaching.

How To Cite Guidelines And Evidence Without Overcomplicating The Letter

You don't need a 12-study bibliography. You need one or two credible anchors.

A simple approach:

Mention FDA approval relevance in one line (for the brand and indication being requested).

Reference one major guideline body briefly (for example, the American Diabetes Association Standards of Care for type 2 diabetes management: or recognized obesity management guidance for chronic weight management).

If you attach supporting documents, label them clearly (Attachment A: Clinician LMN: Attachment B: Relevant chart notes: Attachment C: Labs: Attachment D: Coverage criteria excerpt with highlights).

Keep the tone neutral and clinical:

Avoid: "This medication is life-changing and the only thing that works."

Prefer: "Based on documented diagnosis, prior therapy history, and cardiometabolic risk profile, this medication is medically necessary and consistent with plan criteria."

GLP-1 Appeals Letter Template (Copy And Customize)

These templates are written from your perspective (you, the member). In some cases, your clinician may submit the appeal letter instead, or you may submit yours along with the clinician's Letter of Medical Necessity. Either way, the logic is the same: match criteria, document risk, address the denial reason.

Replace brackets with your details. Keep the formatting clean and easy to scan.

Template For Continuation Of Therapy (If You're Already On A GLP-1)

Date: [Month Day, Year]

To: [Insurance Company] Appeals Department

Fax: [Fax Number] / Address: [Appeals Address]

Re: Appeal for coverage of [Medication name and dose] (continuation of therapy)

Member: [Your full name], DOB: [DOB]

Member ID: [ID], Group: [Group #]

Prescriber: Dr. [Name], NPI: [if available]

Denial date: [Date]

Claim/Reference #: [If provided]

Dear Appeals Reviewer,

I am appealing the denial of coverage for [medication], prescribed by Dr. [Name] for [diagnosis/indication]. The denial reason states: "[quote the denial reason]."

Clinical summary and medical necessity:

1. Diagnosis/indication: [Type 2 diabetes / obesity / other]
2. Current BMI: [#] (documented on [date])
3. Relevant labs (if applicable): A1C [#%] on [date]: fasting glucose [#] on [date]
4. Comorbidities and cardiometabolic risk factors: [hypertension, dyslipidemia, sleep apnea, NAFLD/MASLD, PCOS, etc.]
5. GLP-1 therapy history: I initiated [medication] on [start date] and have been on therapy for [duration].
6. Objective response: Since starting therapy, my documented outcomes include [A1C improvement from X to Y: weight change: other clinically relevant metrics documented in chart].

Reason continuation is medically necessary:

Discontinuing or interrupting therapy risks [loss of glycemic control / weight regain / worsening cardiometabolic risk factors], as documented in my medical record and consistent with the chronic nature of [type 2 diabetes/obesity].

Response to denial reason:

If denial is for quantity limits: The requested quantity and dose align with standard titration/maintenance dosing for [medication]. My prescriber's documentation (Attachment A) supports why this dose is medically appropriate.

If denial is for PA/documentation: The enclosed documents address the missing criteria and demonstrate that I meet the plan's requirements.

Request:

I respectfully request reconsideration and approval for continuation coverage of [medication] at [dose] as prescribed.

Attachments:

Attachment A: Prescriber Letter of Medical Necessity

Attachment B: Relevant chart notes with diagnosis, BMI, and treatment history

Attachment C: Recent labs (A1C, etc.)

Attachment D: Copy of denial letter and highlighted coverage criteria

Sincerely,

[Your full name]

[Phone number]

[Address]

Template For New Start (If You're Not Yet On A GLP-1)

Date: [Month Day, Year]

To: [Insurance Company] Appeals Department

Fax: [Fax Number] / Address: [Appeals Address]

Re: Appeal for coverage of [Medication name and dose] (new start)

Member: [Your full name], DOB: [DOB]

Member ID: [ID], Group: [Group #]

Prescriber: Dr. [Name], NPI: [if available]

Denial date: [Date]

Claim/Reference #: [If provided]

Dear Appeals Reviewer,

I am appealing the denial of coverage for [medication], prescribed by Dr. [Name] for [diagnosis/indication]. The denial reason states: "[quote the denial reason]."

Medical necessity and criteria match:

1. Diagnosis/indication: [Type 2 diabetes / obesity / other]
2. BMI: [#] (documented on [date]). This meets the plan's coverage criterion of [quote the plan criterion and mirror it].
3. Relevant labs (if applicable): A1C [#%] on [date]
4. Comorbidities that increase cardiometabolic risk: [list]
5. Prior treatments attempted: [lifestyle program details if available], and medication trials including [metformin/other agents], with outcomes: [ineffective, not tolerated, contraindicated].

Response to denial reason:

If step therapy: I have [tried/been unable to tolerate/have a contraindication to] the required alternatives, as documented in the attached chart notes. Hence, step therapy is not clinically appropriate for me.

If PA incomplete: The attached documents provide the required clinical information and clarify that I meet the plan's coverage criteria.

If exclusion: I request review of the plan language and medical policy in the context of my documented diagnosis and risk profile, as this prescription is for a medically necessary treatment of a chronic disease, not cosmetic weight loss.

Request:

I respectfully request reconsideration and approval for [medication] as prescribed.

Attachments:

Attachment A: Prescriber Letter of Medical Necessity

Attachment B: Chart notes documenting diagnosis, BMI, comorbidities, and prior therapies

Attachment C: Labs (A1C, etc.)

Attachment D: Copy of denial letter and highlighted coverage criteria

Sincerely,

[Your full name]

[Phone number]

[Address]

What To Emphasize For Specific Situations (Women 35–55, Menopause, And GI Tolerability)

If you're a woman in your late 30s to mid-50s, you're often dealing with a very real overlap: hormonal transition, metabolic slowdown, and rising cardiometabolic risk, even if you "haven't changed anything." Insurance letters don't always leave room for that nuance, but your appeal can.

The goal isn't to tell a personal story. It's to translate your situation into clinical risk and medical necessity.

Metabolic And Hormonal Context: Perimenopause, Weight Gain Patterns, And Cardiometabolic Risk

Perimenopause is the years leading up to menopause when estrogen and progesterone fluctuate. Those shifts are linked to changes in body composition (often more central or abdominal fat), insulin sensitivity, and lipid patterns in many women.

In an appeal, you can't claim hormones "caused" everything, but you can document what's medically relevant:

A clear weight trajectory over time (for example, gradual gain even though documented lifestyle efforts)

Presence of cardiometabolic risk markers: hypertension, dyslipidemia, insulin resistance/prediabetes, sleep apnea, fatty liver disease

Family history of early cardiovascular disease or type 2 diabetes (if documented in your chart)

If you're using a GLP-1 as part of a broader clinician-guided plan (nutrition, resistance training, sleep, stress, sometimes hormone therapy when appropriate), that's worth stating briefly. It signals that the medication is being used in a structured, medically supervised way.

GI Side Effects And Adherence: Showing A Tolerability Plan And Supportive Nutrition

Some denials and discontinuations are indirectly driven by tolerability: nausea, constipation, reflux, or bloating that makes it hard to titrate (increase dose) or stay consistent.

If your situation involves GI tolerability, your appeal packet is stronger when it shows:

You're not requesting a GLP-1 "casually": you're actively managing predictable adverse effects

Your clinician has a plan for slower titration or dose adjustment if needed (when clinically appropriate)

You're addressing hydration, protein intake, and bowel regularity in a structured way

Any prior medication intolerance is documented (for example, you stopped a required step-therapy drug due to side effects)

This is also where it helps to include practical supports that make adherence more likely. A reviewer may not care about your meal plan in detail, but they do care that side effects won't derail treatment and create wasted cost.

For many people on GLP-1 therapy, gut-friendly nutrition choices and targeted digestive support can be the difference between "I had to stop" and "I can stay consistent enough to get results."

Submitting The Appeal And Following Up (Timelines, Fax Numbers, And Call Scripts)

A great letter can still fail if it never reaches the right desk, or if you miss the deadline. Treat the submission step like a mini project.

Practical submission rules that help:

Submit exactly how the denial letter instructs (fax, mail, portal). If they say fax, fax.

Include the denial letter as the first attachment so your packet is routed correctly.

Put your member ID and claim/reference number on every page (header or footer is fine).

Keep a confirmation page or portal receipt.

If you mail it, use certified mail or another trackable method.

Internal Appeal Vs External Review And Expedited Requests

Internal appeal

This is the first level: the insurance company re-reviews the denial. Your denial letter should state how long the plan has to respond.

External review

If the internal appeal is denied, you may have the right to an independent external review (rules vary by plan type and state). The denial letter after your internal appeal typically explains how to request this.

Expedited (urgent) appeal

If waiting could seriously jeopardize your health, your clinician can often request an expedited review. This is especially relevant when a medication interruption is risky (for example, certain diabetes control situations) or when the denial creates a clinically urgent gap.

If you think expedited review applies, ask your clinician's office what they need to submit it as urgent under your plan's definition.

How To Track Your Case And Escalate If You Don't Get A Decision

Tracking is boring, but it wins appeals.

Create a simple log with:

Date submitted

Method (fax/mail/portal)

Confirmation number

Who you spoke with (name, reference number)

Next promised update

Call script you can use:

Hi, I'm calling to confirm receipt and status of my appeal for [medication]. My member ID is [ID] and my appeal/claim reference number is [#].

Can you confirm the date it was received?

What is the deadline for a decision?

Is any additional documentation needed to complete the review?

Can you provide a call reference number for this conversation?

If you don't get a decision by the stated timeline, ask:

Can you escalate this due to overdue determination?

Is there a supervisor review process?

What is the process to request an external review if the timeline is missed or the appeal is denied?

And a real-world tip: if your clinician's office is willing, it often helps to coordinate so both of you are calling. Insurers tend to move faster when the prescriber's staff is also tracking the case.

Conclusion

An effective GLP-1 appeal isn't about writing the most emotional letter, it's about making it easy for a reviewer to approve you based on the plan's own checklist. When you gather the right documents, mirror the criteria, and directly answer the denial reason, you dramatically improve your odds.

If you're in the middle of this process, try not to interpret a denial as a verdict on your health or your effort. It's often just administrative friction around high-cost medications. Handle it like paperwork, build a clean packet, and follow up like it matters (because it does).

GI side effects don't have to be the price of admission for GLP-1 therapy. Casa de Sante offers physician-formulated gut support products built for the specific digestive challenges these medications create. Explore your options at casadesante.com.

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before making changes to your treatment plan.

Frequently Asked Questions (GLP-1 Appeals Letter Template)

What is a GLP-1 appeals letter template, and when should I use it?

A GLP-1 appeals letter template is a copy-and-customize letter you send after insurance denies semaglutide or tirzepatide. Use it for prior authorization denials, step therapy (“fail first”), quantity limits during titration, stopped continuation coverage, or when the denial is vague and missing required documentation.

How do I write a strong GLP-1 appeals letter that proves medical necessity?

A strong GLP-1 appeals letter mirrors your plan’s coverage checklist. Include your member details, quote the denial reason, and give a brief clinical snapshot (diagnosis, BMI, A1C, comorbidities, prior treatments and outcomes). Then explicitly match the plan criteria line-by-line and request reconsideration with labeled attachments.

What documents should I attach to a GLP-1 appeal for semaglutide or tirzepatide?

Attach the denial letter (with deadline), the plan’s clinical/PA criteria for the specific drug, and the submitted prior auth if available. From your clinician, include chart notes showing diagnosis, BMI, A1C/labs, comorbidities, and medication history, plus a Letter of Medical Necessity that addresses the exact denial reason.

How do I appeal a GLP-1 denial for step therapy or “try cheaper meds first”?

For step therapy, don’t argue the GLP-1 is “better” in general—document why the required alternatives aren’t appropriate for you. List what you tried and the results (ineffective), or provide evidence of intolerance/side effects or contraindications. Attach supporting chart notes so the reviewer can verify you meet the exception criteria.

What should I say if my GLP-1 was denied due to quantity limits or a higher dose?

Explain that the requested pens/dose match FDA-labeled titration or standard maintenance dosing and are not “extra medication.” Clarify your current dose, the planned escalation schedule, and why the quantity is medically appropriate. Include your prescriber’s note supporting the dosing plan and any risks of interruption (e.g., worsened A1C).

How long do I have to file a GLP-1 appeal, and can I request an expedited review?

Appeal deadlines are usually stated in the denial letter and commonly range from 30 to 180 days depending on the plan and state rules. If waiting could seriously jeopardize your health (for example, a risky therapy interruption), your clinician can often request an expedited (urgent) appeal under your plan’s definition.